|
NOTE 9 - WARRANTS
Transactions involving the Company equity-classified warrants for the nine months ended June 30, 2026 are summarized as follows:
| | | Number of shares | | | Weighted-average exercise price | | | Weighted-average remaining contractual term (in years) | | | Aggregate intrinsic value (in thousands) | |
| Outstanding at September 30, 2025 | | | 5,901 | | | $ | 244.06 | | | | 3.42 | | | $ | - | |
| Granted | | | - | | | | - | | | | - | | | | - | |
| Exercised | | | - | | | | - | | | | - | | | | - | |
| Forfeited | | | (838 | ) | | | 1,348.16 | | | | - | | | | - | |
| Outstanding at June 30, 2026 | | | 5,063 | | | | 20.16 | | | | 1.95 | | | | - | |
| | | | | | | | | | | | | | | | | |
| Exercisable at June 30, 2026 | | | 5,063 | | | $ | 20.16 | | | | - | | | $ | - | |
The following table summarizes outstanding common stock purchase warrants as of June 30, 2026:
| | | Number of shares | | | Weighted-average exercise price | | Expiration |
| Exercisable at $20.16 per share | | | 5,063 | | | | 20.16 | | April 2028 |
| | | | 5,063 | | | $ | 119.56 | | |
|